Florian P. Reiter

机构：Universitätsklinikum Würzburg, Comprehensive Cancer Center Erlangen · ORCID：0000-0003-3807-1456

发表论文 118 篇 · 总被引 2804 次 · h-index 23

代表论文

• Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy (2024 · Hepatology · 被引 37)
• Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab (2024 · JHEP Reports · 被引 10)
• TACE plus immune checkpoint inhibitor-based systemic therapies for hepatocellular carcinoma (2025 · The Lancet · 被引 9)
• Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real‐World Analysis of the IMMUreal Cohort (2025 · Alimentary Pharmacology & Therapeutics · 被引 7)
• Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity (2025 · JHEP Reports · 被引 5)
• Efficacy of CDK4/6 Inhibition in colorectal cancer and the role of p16 expression in predicting drug resistance (2025 · Cellular Oncology · 被引 4)